Intracerebral microdialysis in neurointensive care: the use of urea as an endogenous reference compound
Authors:
- Elisabeth Ronne-EngströmERElisabeth Ronne-Engström
- Kristina Giuliana CesariniKCKristina Giuliana Cesarini
- Per EnbladPEPer Enblad
- Göran HesselagerGHGöran Hesselager
- Niklas MarklundNMNiklas Marklund
- Pelle NilssonPNPelle Nilsson
- Konstantin SalciKSKonstantin Salci
- Lennart PerssonLPLennart Persson
- Lars HilleredLHLars Hillered
- 1 March 2001
- journal article
- clinical trial
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 94 (3) , 397-402
Abstract
Object. When evaluating the results of intracerebral microdialysis, the in vivo performance of the microdialysis probe must be considered, because this determines the fraction of the interstitial concentration obtained in the microdialysis samples. The in vivo performance is dependent on several factors, for example, the interstitial compartment's diffusion characteristics, which may vary during the course of the acute brain injury process. In the present study the authors investigated the method of controlling the in vivo performance by using urea, which is evenly distributed in all body fluid compartments, as an endogenous reference compound and by comparing the urea levels in three compartments: the brain (CNS), abdominal subcutaneous tissue (SC), and blood serum (BS). Methods. Sixty-nine patients with traumatic brain injury or cerebrovascular disease were included in the study. In 63 of these patients a CNS probe was used, an SC probe was used in 40, and both were used in 34. Urea was measured by enzymatic methods, at bedside for the microdialysis samples and in routine clinical laboratory studies for the BS samples, with the probe calibrated to give identical results. The correlation coefficient for CNS/SC urea was 0.88 (2414 samples), for CNS/BS urea it was 0.89 (180 samples), and for SC/BS urea it was 0.98 (112 samples). Conclusions. Urea levels in the CNS, SC, and BS were highly correlated, which supports the assumption that urea is evenly distributed. The CNS/SC urea ratio can therefore be used for monitoring the CNS probe's in vivo performance. Fluctuations in other substances measured with microdialysis are probably caused by biological changes in the brain, as long as the CNS/SC urea ratio remains constant.Keywords
This publication has 26 references indexed in Scilit:
- Neurochemical monitoring of the acutely injured human brainScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Factors affecting excitatory amino acid release following severe human head injuryJournal of Neurosurgery, 1998
- The effect of 4β-phorbol-12,13-dibutyrate and staurosporine on the extracellular glutamate levels during ischemia in the rat striatumMolecular and Chemical Neuropathology, 1998
- Simultaneous Intracerebral Microdialysis and Positron Emission Tomography in the Detection of Ischemia in Patients with Subarachnoid HemorrhageJournal of Cerebral Blood Flow & Metabolism, 1996
- Overview of chemical sampling techniquesJournal of Neuroscience Methods, 1993
- Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brainThe Lancet, 1993
- Quantitative Examination of Tissue Concentration Profiles Associated with MicrodialysisJournal of Neurochemistry, 1992
- Neurometabolic monitoring of the ischaemic human brain using microdialysisActa Neurochirurgica, 1990
- Brain MicrodialysisJournal of Neurochemistry, 1989
- Determination of Brain Interstitial Concentrations by MicrodialysisJournal of Neurochemistry, 1989